EUVIMEDEUVIMED entdecken
Crossref

Brachytherapy Combined with Cuproptosis-Inducing Radiosensitizer Overcomes Radioresistance in Triple-Negative Breast Cancer

Xue Wang, Chenglu Gu, Jie Zhang, Xihong Guo iD, Shuang Zhu, Shuanglong Du, Chen Yang, Fuquan Zhang, Chunli Luo, Xilin Yang, Xiuxiu Wang, Jingjing Tian und 5 weitere

Nano Letters · 12.08.2026 · 26 (31) · 10434-10445

DOI: 10.1021/acs.nanolett.6c02420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, online erschienen am 02.08.2026. Verfasst von Xue Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Multidisciplinary Department, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing100049, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Copper, Radiation-Sensitizing Agents, Brachytherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acquired radioresistance remains a major clinical obstacle in triple-negative breast cancer (TNBC) radiotherapy. Here, we first report the combined use of an ultrasmall copper-doped hafnium oxide nanoradiosensitizer (US-HfO2:Cu, ∼10 nm) and 192Ir brachytherapy (BT) to address this issue. BT triggers radiation-responsive Cu+ release from US-HfO2:Cu, inducing intracellular copper overload and cuproptosis, while the high-Z HfO2 core enhances radiation energy deposition to aggravate DNA damage. This synergistic biophysical strategy impairs mitochondrial function and activates the cGAS-STING pathway, eliciting immunogenic cell death and robust systemic antitumor immunity. When combined with brachytherapy, US-HfO2:Cu efficiently suppresses primary tumor growth and inhibits distant tumor metastasis via the abscopal effect in the acquired radioresistant TNBC murine model, while minimizing damage to normal tissues. These findings establish a strategy integrating cuproptosis, physical radioenhancement, and immune activation to combat aggressive radioresistant TNBC, holding great clinical translation potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsCopperRadiation-Sensitizing AgentsBrachytherapyRadiation ToleranceCuproptosisAnimalsFemaleHumansMiceCell Line, TumorHafnium

Stichwörter der Autor:innen

brachytherapycuproptosishafnium oxideradioresistancetriple-negative breast cancer

Substanzen

CopperRadiation-Sensitizing AgentsHafnium

Autor:innen und Institutionen

  • Multidisciplinary Department, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing100049, China.
  • University of Chinese Academy of Sciences , Beijing100049, China.
  • Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing100730, People's Republic of China.
  • Department of Radiation Oncology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing100730, Peo…

ORCID-Profile: Xihong Guo, Baoyun Sun, Zhanjun Gu

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • National High Level Hospital Clinical Research Funding
  • Beijing Natural Science Foundation
  • Directional Institutionalized Scientific Research Platform relies on Beijing Synchrotron Radiation Facility of Chinese Academy of Sciences
  • International Scientific Exchange Foundation of China
  • Technology Innovation Program of Institute of High Energy Physics

Zitieren

APA

Wang, X., Gu, C., Zhang, J., Guo, X., Zhu, S., Du, S., Yang, C., Zhang, F., Luo, C., Yang, X., Wang, X., Tian, J., Zhu, J., Zeng, Z., Yan, J., Sun, B., & Gu, Z. (2026). Brachytherapy Combined with Cuproptosis-Inducing Radiosensitizer Overcomes Radioresistance in Triple-Negative Breast Cancer. Nano Letters, 26(31), 10434-10445. https://doi.org/10.1021/acs.nanolett.6c02420

Vancouver

Wang X, Gu C, Zhang J, Guo X, Zhu S, Du S, et al. Brachytherapy Combined with Cuproptosis-Inducing Radiosensitizer Overcomes Radioresistance in Triple-Negative Breast Cancer. Nano Letters. 2026;26(31):10434-10445. doi:10.1021/acs.nanolett.6c02420

BibTeX
@article{Wang2026,
  author = {Wang, Xue and Gu, Chenglu and Zhang, Jie and Guo, Xihong and Zhu, Shuang and Du, Shuanglong and Yang, Chen and Zhang, Fuquan and Luo, Chunli and Yang, Xilin and Wang, Xiuxiu and Tian, Jingjing and Zhu, Jiawei and Zeng, Zheng and Yan, Junfang and Sun, Baoyun and Gu, Zhanjun},
  title = {Brachytherapy Combined with Cuproptosis-Inducing Radiosensitizer Overcomes Radioresistance in Triple-Negative Breast Cancer},
  journal = {Nano Letters},
  year = {2026},
  volume = {26},
  number = {31},
  pages = {10434--10445},
  doi = {10.1021/acs.nanolett.6c02420}
}
Kostenlos starten →